Page last updated: 2024-12-08
tris(2,2'-bipyridyl)cobalt(iii)
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
tris(2,2'-bipyridyl)cobalt(III): RN given for (triperchlorate,(OC-6-11))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 161059 |
MeSH ID | M0306540 |
Synonyms (11)
Synonym |
---|
cobalt(3+), tris(2,2'-bipyridine-n,n')-, (oc-6-11)-, triperchlorate |
cobalt(3+), tris(2,2'-bipyridine-n,n')-, perchlorate (1:3), (oc-6-11)- |
tris(bipyridine)cobalt(iii) perchlorate |
14376-02-4 |
tris(2,2'-bipyridyl)cobalt(iii) |
tris(2,2'-bipyridyl)cobalt(iii) perchlorate |
cobalt trisbipyridyl |
cobpy cpd |
DTXSID00162536 |
tris(2,2/'-bipyridyl)cobalt(iii) |
cobalt(3+);2-pyridin-2-ylpyridine;triperchlorate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |